Key facts
- Ubie’s last known valuation is $216.3M (Apr 2024).
- It has raised $228.9M; the latest was Later Stage VC ($125.0M) in Jun 2025.
- Notable investors include Google for Startups, SBI Investment, J-Startup, Alphabet, Japan Finance Corporation — 30 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 30 names
- ·Watchlist + deal alerts for Ubie
- ·The full record, as it builds
Funding rounds
No funding rounds for Ubie are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ubie
Operator of a global health-tech platform intended to provide artificial intelligence(AI) disease prediction and SaaS products. The company's disease prediction AI determines potential conditions and the next best steps in a patient's care journey based on symptoms and medical history by leveraging technology, enabling healthcare providers to reduce doctor's desk work and patient wait time with solutions designed to improve efficiency and care coordination.
- Sector
- Healthcare
- HQ
- Tokyo, Japan
- Founded
- 2015
- Employees
- 220
- Website
- ubie.life/
- Ownership
- Privately Held (backing)
Ubie doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ubie shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ubie in its N-PORT filings yet. We sweep new filings monthly.